AI-generated summary
The authors randomized eight patients with dementia to 12 weeks of usual care or home near-infrared photobiomodulation using a headset device. The PBM group showed reported improvements in cognitive and behavioral scores, cerebral perfusion, and default-mode network connectivity compared with the usual care group. The sample was very small, so these findings are preliminary.
- Participants
- 8
- Who or what was studied
- Patients with dementia (mean age 79.8 years), diagnosed by their physicians
- Limits stated in the abstract
- Very small pilot sample of eight participants randomized into groups of four, which limits the strength of the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Dementia, Near-infrared, Intranasal photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.